Product Information

LEVOCETIRIZINE 2.5 MG/5 ML SOL is a generic product labeled by Chartwell RX LLC, priced at $0.1659 per ML under NDC 62135091738. Its NADAC has been published 184 times since Feb 15, 2023.

FDA first approved this application on May 15, 2017. Its Orange Book therapeutic-equivalence code is AA.

LEVOCETIRIZINE 2.5 MG/5 ML SOL

Levocetirizine Dihydrochloride
$0.1659per ML

Strength

.5 mg/mL

Manufacturer

Chartwell RX LLC

NDC

62135091738

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204599

FDA Approved

5/15/2017

TE Code

AA

On Market Since

5/15/2017

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has been published 184 times since Feb 15, 2023, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1659 per ML
All-time high$0.2218 (Feb 14, 2024)
All-time low$0.1180 (Nov 20, 2024)
52-week high$0.1740
52-week low$0.1409
Median price$0.1669
Average price$0.1716
Largest weekly change-33.4% (Nov 20, 2024)
Weeks tracked184
Tracking sinceFeb 15, 2023

Price History

1W

+4.9%

1M

+4.9%

3M

+10.7%

6M

+11.9%

1Y

-4.7%

3Y

-25.0%

5Y

N/A

All

-8.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levocetirizine Dihydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LEVOCETIRIZINE 2.5 MG/5 ML SOL?

The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 2.5 MG/5 ML SOL, manufactured by Chartwell RX LLC, is $0.1659 per ML (NDC 62135091738), effective Aug 19, 2026.

How has the price of LEVOCETIRIZINE 2.5 MG/5 ML SOL changed over time?

Over the history we have for it, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has declined 8.9%. It has been tracked across 184 weekly CMS publications since Feb 15, 2023.

What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 2.5 MG/5 ML SOL?

Since Feb 15, 2023, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has ranged from a low of $0.1180 (Nov 20, 2024) to a high of $0.2218 (Feb 14, 2024), with a median of $0.1669 per ML.

Are there cheaper alternatives to LEVOCETIRIZINE 2.5 MG/5 ML SOL?

No other NADAC-published product currently shares the active ingredient and strength of LEVOCETIRIZINE 2.5 MG/5 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LEVOCETIRIZINE 2.5 MG/5 ML SOL?

LEVOCETIRIZINE 2.5 MG/5 ML SOL (NDC 62135091738) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.